The expression of CA-IX is limited in normal tissues, and its overexpression correlated with a poor prognosis has been observed in many solid malignancies, including breast, lung, ovary, head and neck, bladder, colon, cervix, renal cancers, and glioblastoma [41–44]. Here, CA9 is linked to glioblastoma.